Evidence map›Paper›PMID 29447181›Full record

ArticlePloS one2018

Innate immune responses following Kawasaki disease and toxic shock syndrome.

Katherine Y H Chen, Nicole Messina, Susie Germano, Rhian Bonnici, Bridget Freyne, Michael Cheung, Greta Goldsmith, Tobias R Kollmann, Michael Levin, David Burgner and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Association betweenFrontiers in medicine · 2023
    Article
  4. Article
  5. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.Journal of the Formosan Medical Association = Taiwan yi zhi · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. TheJournal of immunology research · 2019
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Katherine Y H ChenMurdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Vic, Australia.ORCID 0000-0003-3301-8031
Nicole MessinaMurdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Vic, Australia.
Susie GermanoMurdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Vic, Australia.
Rhian BonniciMurdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Vic, Australia.
Bridget FreyneMurdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Vic, Australia.
Michael CheungHeart Research Group, Murdoch Children's Research Institute and Department of Cardiology, The Royal Children's Hospital, Melbourne, Vic, Australia.
Greta GoldsmithHeart Research Group, Murdoch Children's Research Institute and Department of Cardiology, The Royal Children's Hospital, Melbourne, Vic, Australia.
Tobias R KollmannDivision of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Michael LevinPaediatric Infectious diseases group, Division of Medicine, Imperial College London, London, United Kingodm.
David BurgnerMurdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Vic, Australia.
Nigel CurtisMurdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Vic, Australia.
Royal Children's Hospital · AUImperial College London · GBUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathogenesis of Kawasaki disease (KD) remains unknown and there is accumulating evidence for the importance of the innate immune system in initiating and mediating the host inflammatory response. We compared innate immune responses in KD and toxic shock syndrome (TSS) participants more than two years after their acute illness with control participants to investigate differences in their immune phenotype. Toxic shock syndrome shares many clinical features with KD; by including both disease groups we endeavoured to explore changes in innate immune responses following acute inflammatory illnesses more broadly. We measured the in vitro production of interferon (IFN)-γ, tumour necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, IL-1 receptor antagonist (IL-1ra), and IL-10 following whole blood stimulation with toll-like receptor and inflammasome ligands in 52 KD, 20 TSS, and 53 control participants in a case-control study. Analyses were adjusted for age, sex, and unstimulated cytokine concentrations. Compared to controls, KD participants have reduced IL-1ra production in response to stimulation with double stranded RNA (geometric mean ratio (GMR) 0.37, 95% CI 0.15, 0.89, p = 0.03) and increased IL-6 production in response to incubation with Lyovec™ (GMR 5.48, 95% CI 1.77, 16.98, p = 0.004). Compared to controls, TSS participants have increased IFN-γ production in response to peptidoglycan (GMR 4.07, 95% CI 1.82, 9.11, p = 0.001), increased IL-1β production to lipopolysaccharide (GMR 1.64, 95% CI 1.13, 2.38, p = 0.01) and peptidoglycan (GMR 1.61, 95% CI 1.11, 2.33, p = 0.01), and increased IL-6 production to peptidoglycan (GMR 1.45, 95% CI 1.10, 1.92, p = 0.01). Years following the acute illness, individuals with previous KD or TSS exhibit a pro-inflammatory innate immune phenotype suggesting a possible underlying immunological susceptibility or innate immune memory.

Indexed as

Immunity, InnateAdolescentAdultCase-Control StudiesChildFemaleHumansInflammasomesMaleMucocutaneous Lymph Node SyndromeShock, SepticToll-Like ReceptorsYoung AdultInflammasomesToll-Like Receptors

Identifiers

PMID29447181
PMCPMC5813928
OpenAlexW2789765363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.